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Establishing pig embryonic stem cells (pESCs) remains a challenge due to 
differences in the genetic backgrounds of mouse, human, and pig. Therefore, pig-
specific pluripotency markers and their cellular signaling must be identified. In this 
study, doxycycline (DOX)-inducible vectors carrying Oct4, sex determining region Y-
box 2 (Sox2), Nanog, Kruppel-like family 4 (Klf4), and Myc, which are known 
reprogramming factors, were transduced into pESCs to analyze the pluripotent gene 
network. Pig ESCs were stably maintained in basic fibroblast growth factor (bFGF)-
supplemented media, when cultured without DOX. However, when treated with DOX, 
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the cells lost their alkaline phosphatase activity and differentiated within two weeks. 
Subsequently, we investigated the expression of genes related to pluripotency in DOX-
treated pESCs using quantitative reverse transcription PCR. Expression levels of Oct4, 
E-cadherin, and Fut4 were significantly increased by Oct4 overexpression, and Fut4 
were upregulated in the Sox2 overexpressed group. When a combination of two 
reprogramming factors, Oct4 or Sox2 was introduced, weak alkaline phosphatase 
activity remained. In addition, Oct4 and Nanog, Oct4 and Klf4, or Sox2 and Nanog 
combinations transduction groups could be maintained after subculturing with 
transgene activation. Although a long-term culture failed, pESCs transduced with Oct4 
and Nanog, Oct4 and Klf4, or Sox2 and Nanog combinations could be subcultured even 
under transgene activation conditions. Analysis of the cause of long-term culture failure 
by quantitative real-time PCR (qPCR) confirmed that the expression of intermediate 
reprogramming markers such as Lin28 and Sall4 was not maintained. Given these 
results, additional strategies are needed to support the completion of each 
reprogramming phase to succeed in the conversion of the pluripotent state of pESCs. 
The present study improve our understanding of pluripotent networks and could be used 
to aid in the establishment of bona fide pig pluripotent stem cells. 
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1. Overview of Embryonic stem cells (ESCs)  
 
 All creatures start from fertilized eggs. Embryos have totipotency, which is the 
ability to differentiate into tissues and organs to form an organism. Embryos form 
blastocysts as development progresses. The outside of the blastocysts consists of 
trophoblast cells that differentiate into the placenta, and the inside consists of an inner 
cell mass (ICM) that becomes the fetus. The cells of the ICM are no longer totipotent, 
but have pluripotency which is the ability to differentiate into all layered cells. ESCs 
derived from the ICM also have pluripotency and self-renewal capacity. One of the 
earliest and most well established stem cell models for pluripotency is mouse 
embryonic stem cells (mESCs), which were derived from the ICM of the mouse 
blastocyst nearly three decades ago(Evans and Kaufman 1981; Martin 1981). mESCs 
have met the criteria that define all pluripotency, such as pluripotency marker 
expression, single cell clonogenecity, and chimeric mice formation as well as successful 
tetraploid complementation assay. Based on these results, mESCs were used as a useful 
model for molecular studies of pluripotent states. Early studies have led to the discovery 
of the core pluripotency factors, namely Oct4, Sox2 and Nanog in mouse embryos and 
mESCs (Chambers and Tomlinson 2009). Disruption of Oct4 caused aberrant 
differentiation of the ICM to the trophectoderm (TE) lineage instead of the embryo 
12 
 
(Nichols et al. 1998), Nanog null ICM failed to develop into epiblast (Silva et al. 2009), 
while Sox2 Knockout in mice conferred early embryonic lethality (Avilion et al. 2003). 
The fact that the three genes play an important role in pluripotency formation was found 
by the Oct4, Sox2 and Nanog blocking experiments in early embryos.  
Genome-wide chromatin immunoprecipitation (ChIP) studies revealed that Oct4, 
Sox2 and Nanog co-bind to the promoters of many genes in both mESCs and human 
ESCs (hESCs) (Boyer et al. 2005; Loh et al. 2006). Notably categories of co-bound 
target genes include signaling intermediaries, micro-RNAs, chromatin-remodeling and 
histone modifying proteins, hence establishing a direct link between the core 
transcriptional network and other key aspects of pluripotency regulation. These studies 
also indicate that the core transcriptional factors maintain ESCs by activating other 
pluripotency factors, such as Esrrb and Zic3, coincident with repressing developmental 
genes such as Cdx2 to suppress differentiation. Oct4, Sox2 and Nanog activate 
themselves and also each other, constituting a core transcriptional regulatory network 
with features of auto-activation and feed-forward loops (Boyer et al. 2005; Loh et al. 
2006; Chew et al. 2005; Kuroda et al. 2005; Okumura-Nakanishi et al. 2005; Rodda et 
al. 2005). In addition to transcription factors, external stimuli, such as culture conditions, 
also contribute to the maintenance of stemness by engaging in the signaling pathways 
of the ESCs. Initially, mESCs were cultured on mouse embryonic fibroblasts (MEFs) 
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by using a medium supplemented with fetal calf serum (FCS). Later, FCS could be 
replaced with BMP4 (Ying et al. 2003) and MEFs could be replaced with cytokine, 
Leukemia inhibitory factor (LIF) (Niwa et al. 1998). The chemicals required for the 
cultivation of mESCs affect a variety of transcription factors and signaling pathways. 
BMP4 induces transcription factor, Smad1 and inhibitor of differentiation (Id) proteins, 
which inhibit neural-specific differentiation (Ying et al. 2003). On the other hand, LIF 
mediates its action by multiple signaling pathway for cellular proliferation, including 
the LIF-STAT3, mitogen-activated protein kinase (MAPK) and phosphatidylinositol-
3-kinase (PI-3K) pathways. The use of MEK inhibitors in the culture of mESCs results 
in a much better self-renewal status, since the MEK inhibitor blocks the MAPK 
pathway (Burdon et al. 1999). When the MAPK pathway was inhibited, PI-3K was 
inactivated and helped to maintain undifferentiated state (Paling et al. 2004). In the 
absence of LIF, BMP4 redirects cells to non-neural differentiation, and the basis of this 
differentiation propensity is due to activation of the fibroblast growth factor (FGF)-
extra –cellular signal-regulated kinase (ERK) pathway (Kunath et al. 2007). In order to 
maintain the characteristics of ESCs, various factors inside and outside of the cell must 
be harmonized. If any of these factors are not working properly, ESCs lose pluripotency 
and become differentiated. Therefore, it is important to understand functions of the 
factors that make up the pluripotency network and to study the mutual relationship. A 
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deep understanding of pluripotency can be useful in a variety of ways, including cell 
therapy, developmental models, and disease research. 
  
2. Naïve and primed pluripotent states 
 
It was two decades after the discovery of mESCs that hESCs were established in 
culture (Thomson et al. 1998). Although hESCs are derived from the ICM, many 
striking differences from mESCs were observed such as morphology, marker 
expression, transcription factor binding activities and culture requirements. Intriguingly, 
it was later found that hESCs resemble more closely to mouse epiblast stem cells 
(EpiSCs), which were derived from post-implantation late epiblasts of the mouse 
(Brons et al. 2007; Tesar et al. 2007). Like embryonic stem cells, EpiSCs had the ability 
to differentiate into three germ layers and has self-renewal ability, but there were slight 
differences in the characteristics of cells and molecules. Morphology also grew into flat 
single layer form completely was different from the compact form of the mESCs 
colonies, whereas mESCs were capable of single cell cloning, but EpiSCs were 
vulnerable to single cell cloning. 
Apart from morphological and molecular differences, EpiSCs differ from mESCs on 
the level of pluripotency that can be attained by various standard assays (Kuijk et al. 
2011). EpiSCs can form teratomas in vivo, but they neither form chimeras nor contribute 
to the germline like mESCs. (Brons et al. 2007; Tesar et al. 2007) Recently, a number 
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of studies have reported that pluripotent stem cells can be categorized as naïve or primed 
according to the level of pluripotency (Nichols and Smith 2009; Hanna et al. 2010). 
mESCs represent naïve pluripotent stem cells, whereas human and large animal ESCs 
and EpiSCs are considered to be in the primed state. A vigorous comparison and 
analysis of naïve and primed states revealed features of the naïve and primed pluripotent 
states as shown below (Table. 1).  
Naïve pluripotent stem cells include mESCs and mouse embryonic germ cells 
(mEGCs). Naïve pluripotent cells form dome-shaped colonies, which are self-renewing 
via LIF signaling. In addition, ESCs derived from female cells have two active X 
chromosomes. On the other hand, primed pluripotent stem cells with a flat colonies and 
undergo self-renewal via FGF signaling. Primed pluripotent stem cells exhibit a greater 
differentiated status than naïve pluripotent stem cells in terms of developmental 
capacity, gene expression, and epigenetic signature. In addition, naïve pluripotent stem 
cells have a higher transgenic efficiency than primed pluripotent stem cells. Naïve 
pluripotent stem cells can produce chimeric embryos via injected into recipient 
blastocysts. Furthermore, the differentiation ability of naïve pluripotent stem cells can 
be confirmed in vitro, as well as to form teratomas via subcutaneous injection. However, 
primed pluripotent stem cells have only been verified for their ability to differentiate in 
vitro, and have failed in vivo differentiation assays such as the production of chimeric 
fetus and teratoma assays. Taken together, these characteristics indicate that naïve 
pluripotent stem cells have a higher degree of pluripotency than primed pluripotent stem 
cells. Thus, many studies have been attempted to the conversion of primed pluripotent 
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cells into naïve pluripotent cells (Yang et al. 2010; Guo et al. 2009; Bao et al. 2009).  
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Table 1. Naïve and primed pluripotent cell properties.  
 Naïve pluripotent state Primed pluripotent state 
Colony morphology Dome-shape Flatten-shape 
Single cell cloning High Low 
Dominant Oct4 enhancer Distal enhancer Proximal enhancer 
Response to LIF/STAT3 Self-renewal None 
Response to FGF/ERK Differentiation Self-renewal 
Pluripotency marker 
Oct4, Sox2, Nanog, Ssea1, 
Klf2, Klf4, Rex1, Stella, 
Dax1 
Oct4, Sox2, Nanog, Ssea4 
X chromosome inactivation in 
female cells 
Two active X chromosomes 
One inactive X chromosome 
and one active chromosome 
Tetraploid complementation Yes No 




3. Pluripotency state conversion  
 
Interest in pluripotency was heightened after the report that it was classified as naïve 
state and primed state according to the level of pluripotency. In addition, many 
researchers have tried to overcome the limitations of primed pluripotent stem cells by 
various artificial methods. Stem cells in the naive state include mESCs, and 
representative stem cells in the primed state included EpiSCs and hESCs. mESCs were 
pluripotent stem cell models with the most ideal pluripotency and EpiSCs had similar 
characteristics of hESCs and were being studied extensively as hESCs models. So 
studying mESCs and EpiSCs will be very helpful in converting hESCs to naïve 
pluripotent stem cells.  
In terms of similarity to induced pluripotent stem cells (iPSCs) reprogramming, 
transcription factor mediated approaches has been a prominent choice. As EpiSCs do 
not express Klf4 or Klf2 as opposed to mESCs, it may be intuitive to reintroduce these 
key pluripotency transcription factors in an attempt to recapitulate mESC expression 
levels. Transfection with Klf4 under GSK and ERK pathway inhibitor (2i)/LIF 
conditions generated converted cells, termed as Epi-iPSC, which exhibited mESC 
morphology and marker profile, and could contribute to germline-competent chimeras 
(Guo et al. 2009). Given the high functional redundancy among members of the 
Kruppel-like family, Klf2 can substitute for Klf4 in the generation of Epi- iPSCs under 
GSK and ERK pathway inhibitor (2i)/LIF conditions (Hall, Guo, et al. 2009). In 
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addition, Klf2 was introduced into EpiSCs instead of Klf4 and cultured with 2i and LIF 
to support the conversion into a naïve-like state. Klf2 and Klf4 target several 
pluripotency genes in common with Nanog, which regulate Nanog expression (Hall, 
Guo, et al. 2009). Therefore it is likely that Nanog could potentially mediate the same 
reprogramming process. Indeed, transfection of Nanog induced a similar reversion of 
EpiSCs to a mESCs like phenotype under 2i/LIF conditions at a 10-fold higher 
efficiency than Klf4 transfection (Silva et al. 2009). Unlike Klf4, however, Nanog-
mediated EpiSC reprogramming can occur under LIF/BMP4 conditions without the 
need for 2i. These Nanog-induced Epi-iPSCs exhibit an mESC-like expression profile, 
including upregulation of Klf4. Transient transfection of Nanog, however, did not yield 
any stable Epi-iPSCs and chimera formation, which was only observed upon co-
transfection with Klf4 (Yang et al. 2010). Therefore, Klf4 and Nanog may function 
synergistically in the conversion of EpiSC to a mESC-like state. Similar success has 
been achieved by other chemical-assisted reprogramming approaches that do not 
involve the exogenous introduction of specific transcription factors. mESC-like cells 
can also be generated from EpiSCs under purely 2i/LIF conditions without the need for 
transcription factors, and these cells have displayed chimera formation as well as 
germline transmission (Greber et al. 2010). One possible explanation is that inhibition 
of the FGF/ERK pathway induces Klf2 expression in EpiSCs (Greber et al. 2010). A 
more diverse inhibitor cocktail has also been established for the conversion of EpiSC 
to a mESC-like state. A combination of parnate and transforming growth factor (TGF)-
ß inhibitor, can reprogrammed EpiSCs to cells that can contribute to germline (Zhou et 
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al. 2010). Parnate can induce a global increase in the activating H3K4 methylation and 
is postulated to activate previously silenced pluripotency genes (Lee et al. 2006), 
highlighting the importance of epigenetic modification in facilitating cellular 
conversions. Unlike other studies that require 2i conditions, Surani and co-workers (Bao 
et al. 2009) reported that EpiSCs could be reprogrammed into mESC-like cells in the 
presence of LIF/FCS and MEF feeder cells. These reprogrammed epiblast ESC-like 
cells show gradually increasing similarity to mESCs in their gene expression profile 
with more passages, including an upregulation of E-cadherin. E-cadherin, a 
transmembrane molecule involved in intercellular adhesion, was previously shown to 
be stimulated by LIF/BMP4 and correlated with differentiation capability (Chou et al. 
2008). Furthermore, knockout of E-cadherin traps cells in a partially reprogrammed 
state (Lee et al. 2006). Taken together, these studies indicate a potential requirement for 
E-cadherin in attainment of pluripotency. LIF is an essential component of traditional 
mESC culture medium, and is frequently added to 2i cultures. Therefore, it would be 
informative to determine the effect of LIF, especially LIF-STAT3 pathway, in 
reprogramming. It was shown that STAT3, while insufficient on its own, can increase 
the efficiency of EpiSCs reprogramming by several fold when used in combination with 
Klf4 or Nanog transfection, indicating that the enhancing effects of STAT3 extends 
beyond direct activation of these pluripotency factors (Lee et al. 2006). A transient 
activation of STAT3, followed by transfer to 2i/LIF culture can recapitulate the effects 
of continuous STAT3 activation (Lee et al. 2006), suggesting that a transient activation 
of LIF-STAT3 is sufficient to prime EpiSCs for reprogramming. A recent study 
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demonstrated that hESC can be converted to a naïve, or mESC-like state by the 
constitutive expression of Oct4 and Klf4 or Klf4 and Klf2 under 2i/LIF conditions 
(Hanna et al. 2010). These naïve hESCs gained a mESC-like colony morphology, 
displayed pre-X-inactivation status and survived single-cell passaging as well as 
inhibition of Activin/Nodal signaling. However, the naïve hESCs rapidly differentiated 
when the exogenous transcription factors were removed, unless Forskolin was added, 
which prolonged the maintenance of the cells (Hanna et al. 2010). Forskolin acts partly 
by inducing Klf4 and Klf2, emphasizing the importance of KLF factors in maintenance 
of the naïve state. There have been other efforts towards achieving certain 
characteristics of mESCs. In the presence of LIF, the combination of MEK and p38 
inhibitors can convert hESCs to mESC-like cell type (Xu et al. 2010). Cell passaging, 
a property that was correlated to an increased expression of E-cadherin and reduced 
dependent on integrin signaling. Although further characterization of the converted 
hESCs is required, this study suggests that a switch in cell adhesion systems may be 
required for hESCs to acquire certain mESC-like properties.  
Besides cell adhesion molecules, atmospheric oxygen levels can also possibly affect 
maintenance of pluripotency. According to Lenger et al., when the hESCs were 
incubated at 5% oxygen concentration, the XIST promoter region was methylated and 
the inactive X chromosome becomes active. According to Lenger et al., when the 
hESCs were incubated at 5% oxygen concentration, the XIST promoter region was 
methylated and the inactive X chromosome became active. In addition, many 
researchers were trying to establish naïve pluripotent stem cells in large animals. 
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Roberts et al., 2011, transduced Oct4 and Klf4 to ICM of porcine blastocysts and derived 
pESCs. These pESCs were self-renewed by LIF and succeeded to differentiate into 
three germ layers in the teratoma formation assay (Telugu et al. 2011). Many studies 
had been conducted to induce pluripotent state conversion through various methods 
such as introducing of exogenous factors, addition of chemicals to culture media, and 
oxygen concentration control. 
 
4. Phase of reprogramming 
 
In 2006, Takshi and Yamanaka published their milestone strategy to reprogramme 
somatic mammalian cells to iPSCs by overexpression of only four transcription factors 
(Takahashi et al. 2007; Takahashi and Yamanaka 2006). Since then, a number of 
scientists conducted research to uncover the reprogramming process. The most obvious 
method of analyzing the complex molecular mechanism of reprogramming was to 
examine how the cell population changes over time after the introduction of 
reprogramming factors. According to this study, reprogramming can be divided into 
two stages. The first step was the stochastic phase, which takes a relatively long time 
and applies only to a few of the many candidate cells(Buganim, Faddah, and Jaenisch 
2013). Cells that have undergone the stochastic step go into the second step and undergo 
a process of rapid reprograming. This second step was called deterministic phase. 
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 When Oct4, Sox2, Klf4 and Myc were introduced into fibroblasts, some cells may 
have various fates when stochastic gene expression begins (apoptosis, aging, 
transformation, transdifferentiation and reprogramming). Among them, the cells that 
become iPSCs were largely reprogrammed through the early, middle and the late stages. 
When reprogramming factors are introduced into somatic cells, Ccnd1, Ccnd2 and 
genes involved in DNA replication, which are related in cell proliferation, are expressed 
at an early stage. The ratio of S phase in the cell cycle increases. The genes expressed 
in somatic cells (Snai1, Snai2, Thy1) are less expressed by histone modification. At the 
early stage, the reprogrammed cells are transferred to the intermediate stage and become 
round and dense in shape. Interior of the cells, TGF-ß signaling is suppressed inside the 
cells and pro-mesenchymal to epithelial transition (MET) micro RNAs are activated. 
As a result, bone morphogenetic protein (BMP) signaling is enhanced and MET begun 
(Mikkelsen et al. 2008; Samavarchi-Tehrani et al. 2010; Koche et al. 2011). 
 Cells at this stage exhibit stochastic activation of markers related with 
pluripotency (Buganim et al. 2012), and developmental regulators (Polo et al. 2012) 
and glycolysis (Hansson et al. 2012) are activated. After this step, genes like 
undifferentiated embryonic cell transcription factor1 (Utf1), oestrogen-related receptor 
beta (Esrrb), developmental pluripotency associated 2 (Dppa2), Sall4 and Lin28 are 
highly expressed and these genes activate Sox2. When Sox2 is activated, a deterministic 
event occurs either directly or indirectly. Cells that reached the late stage are stably 
pluripotent and could remain pluripotent despite inactivating the transgene. In later 
phase, the cytoskeleton redesigns the cell morphology to an ESC-like shape. And 
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repressive chromatin characters such as H3k27 or H3k9 disappear from the 
pluripotency core transcription factor and activate the pluripotency circuitry. When the 
pluripotency circuitry is activated, Oct4, Nanog, Rex1 and Esrrb are highly expressed, 
and pluripotent state is maintained even when ectopically introduced reprogramming 
factors are removed (Golipour et al. 2012; Polo et al. 2012; Hansson et al. 2012; 
Buganim et al. 2012). 
 
5. Studies for pESCs  
 
Pigs are physiologically similar to humans, and pESCs are of interest as models of 
human disease research (Brevini et al. 2007; Hall 2008; Houdebine 2009). Many 
research groups have long tried to derive pluripotent cells from porcine early embryos. 
In 1990, several reports on the first pESC derivation were published (Notarianni et al. 
1990; Evans et al. 1990; Strojek et al. 1990; Piedrahita, Anderson, and Bondurant 1990). 
The first pESCs were identified based on morphological criteria, and there were no 
reports of reliable markers. Alkaline phosphatase (AP) (Talbot et al. 1993) and stage-
specific embryonic antigen-1 (Wianny, Perreau, and Hochereau de Reviers 1997) were 
then identified in pESCs that have been demonstrated to be undifferentiated. However, 
these studies were based on undifferentiated mESCs markers and lacked studies on pig 
specific markers. pESCs are primed pluripotent stem cells that can differentiate into all 
three germ layers in vitro (Piedrahita et al. 1999; Piedrahita, Anderson, and Bondurant 
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1990; Wianny, Perreau, and Hochereau de Reviers 1997), but do not exhibit in vivo 
differentiation ability because the pluripotency level of pESCs are not as high as the 
pluripotent level of naïve pluripotent cells (Mueller et al. 1999; Piedrahita et al. 1998; 
Shim et al. 1997). It is fair to say that research on the specific characteristics of pESCs 
are lacking.  
If overcome these barriers, studies are underway to convert pig embryonic stem cells 
into naïve state. Most studies on pluripotent state conversion to porcine embryonic stem 
cells have proceeded in a way that applies research that had succeeded in converting 
primed pluripotent stem cells such as hESCs or EpiSCs into a naïve pluripotent state. 
However, this approach did not apply to pESCs. Because of the different molecular 
mechanisms in embryonic development, the reprogramming conditions of mouse and 
humans could not be easily applied to pigs. Pigs require a longer period of time to 
implant embryos than mouse and humans (Alberio and Perez 2012). Thus, the signal 
regulating the pluripotency of pig ICM is different from that of mouse embryos. Unlike 
mouse, pigs show Oct4 and Cdx2 in ICM and TE. Conversely, Sox2 is expressed from 
the beginning of embryo cavitation, and when it is divided into TE/ICM, it appears only 
specifically in the embryo and progressively disappeared as the differentiation 
progresses. ICM cells and epiblasts of pig blastocysts do not have LIF receptors, but 
FGF receptors are highly expressed. Thus, FGF signaling plays an important role in 
maintaining the pluripotency of pigs over LIF signaling (Hall, Christensen, et al. 2009). 
In addition, strong expression of BMPr and SMAD in porcine ICM cells and EpiSCs 
was detected by in vitro immunostaining and BMP signaling inhibitor experiments. 
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Treatment of porcine ICM cells and EpiSCs cells with BMP inhibitors in vitro reduced 
cell viability (Hall and Hyttel 2014). BMP signaling also plays an important role in 
maintaining pig pluripotency. (Zhang et al. 2015) recently succeeded in generating 
‘intermediate’ porcine pluripotent stem cells with naïve and primed characteristics even 
when the transgene was removed using three growth factors (LIF, FGF2, and BMP4) 
and the inhibitor 2i. These results show that the pluripotent stem cells of pigs maintain 



















Pigs are physiologically similar to humans, and pESCs have attracted attention as a 
human disease research model (Brevini et al. 2007; Hall 2008; Houdebine 2009). Many 
research groups have long tried to isolate pluripotent cells from porcine early embryos. 
In 1990, several reports of the first pESC isolation were published (Evans et al. 1990; 
Notarianni et al. 1990; Piedrahita, Anderson, and Bondurant 1990; Strojek et al. 1990) 
The first pESCs were identified based on morphological criteria, and there were no 
reports on the reliable markers. Then, AP (Talbot et al. 1993) and stage-specific 
embryonic antigen-1(Wianny, Perreau, and Hochereau de Reviers 1997) were identified 
in pESCs, which were proven to be undifferentiated. However, these studies markers 
were based on markers of undifferentiated mESCs, and studies on pig-specific markers 
were lacking. pESCs are primed pluripotent stem cells that can differentiate into all 
three germ layers in vitro, (Piedrahita et al. 1999; Piedrahita, Anderson, and Bondurant 
1990; Wianny, Perreau, and Hochereau de Reviers 1997), but fail to show any in vivo 
differentiation ability because the pluripotency level of pESCs is not as high as that of 
naïve pluripotent cells (Mueller et al. 1999; Piedrahita et al. 1998; Shim et al. 1997). It 
is fair to say that there a lack of research on the specific characteristics of pESCs. 
Recently, a number of studies have reported that pluripotent stem cells can be 
categorized as naïve or primed according to the level of pluripotency (Nichols and 
Smith 2009; Hanna et al. 2010). mESCs represent naïve pluripotent stem cells, whereas 
human and large animal ESCs and EpiSCs are considered to be in the primed state. 
Naïve pluripotent cells form dome-shaped colonies and are self-renewing via LIF 
signaling. In addition, ESCs obtained from female cells have two active X 
29 
 
chromosomes. In contrast, primed pluripotent stem cells form flat colonies and undergo 
self-renewal via FGF signaling. Primed pluripotent stem cells show a greater 
differentiated status than naïve pluripotent stem cells in terms of developmental capacity, 
gene expression, and epigenetic signature. Meanwhile, naïve pluripotent stem cells 
have a higher transgenic efficiency than primed pluripotent stem cells. Naïve 
pluripotent stem cells can be injected into recipient blastocysts to produce chimeric 
embryos. Furthermore, the differentiation ability of naïve pluripotent stem cells can be 
confirmed in vitro, and can form teratomas via subcutaneous injection. However, 
primed pluripotent stem cells have only been verified for their ability to differentiate in 
vitro, and have failed in vivo differentiation assays such as the chimeric fetus and 
teratoma assays. Together, these characteristics indicate that naïve pluripotent stem cells 
have a higher degree of pluripotency than primed pluripotent stem cells. Thus, many 
studies have been conducted on the conversion of primed pluripotent cells into naïve 
pluripotent cells (Bao et al. 2009; Guo et al. 2009; Yang et al. 2010).  
Many recent studies have compared the conversion of primed pluripotent stem cells 
into naïve pluripotent stem cells and the reprogramming of somatic cells into iPSCs. 
The reprogramming of somatic cells into iPSCs requires sequential steps. When 
reprogramming factors are introduced into somatic cells, Ccnd1, Ccnd2, and genes 
involved in DNA replication, which are involved in cell proliferation, are expressed at 
an early stage. This increases the ratio of the S phase in the cell cycle. The genes 
expressed in somatic cells (Snai1, Snai2, and Thy1) are downregulated via histone 
modification. Then, the reprogrammed cells in the early stage are transferred to the 
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intermediate stage, and their shape becomes rounder and denser (Mikkelsen et al. 2008; 
Samavarchi-Tehrani et al. 2010; Koche et al. 2011). Inside the cells, TGF-ß signaling is 
suppressed and pro-MET microRNAs are activated. As a result, BMP signaling is 
enhanced and MET occurs. Cells at this stage exhibit stochastic activation of markers 
associated with pluripotency (Buganim et al. 2012), and developmental regulators (Polo 
et al. 2012) and glycolysis are activated (Hansson et al. 2012). After this step, genes 
such as Utf1, Esrrb, Dppa2, Sall4, and Lin28 are highly expressed, which activate Sox2. 
The activation of Sox2 causes deterministic events either directly or indirectly. In the 
late phase, the cytoskeleton redesigns the cell morphology into an ESC-like shape. 
Repressive chromatin characteristics, such as H3k27 or H3k9, disappear from the 
pluripotency core transcription factors, activating pluripotency circuitry. When 
pluripotency circuitry is activated, Oct4, Nanog, Rex1, and Esrrb are highly expressed, 
and the pluripotent state is maintained even when the reprogramming factors that were 
introduced ectopically are removed (Buganim et al. 2012; Golipour et al. 2012; Hansson 
et al. 2012; Polo et al. 2012).  
In this study, we overexpressed reprogramming factors in primed pESCs and 
analyzed the changes that occurred in endogenous genes related to pluripotency. This 
study improves our understanding of pluripotent networks and can be used to aid in the 



















1. Animal care  
 
The care and experimental use of pigs and mice was approved by the Institutional 
Animal Care and Use Committee at Seoul National University [Approval No.: ILAR-
17-06-192 for MEF isolation]. The ovaries used in the present study were donated from 
local slaughterhouses (Dodram, Korea; Samsung, Korea) for research purposes. 
Pregnant ICR mice were purchased from Samtaco Bio Inc., Korea. The mice were cared 
for according to the standard protocol of the Institute of Laboratory Animal Resources 
and sacrificed by cervical dislocation after anesthesia. 
 
2. Lentiviral transduction of reprogramming factors  
 
Production and transduction of lentiviral vectors with inducible systems containing 
human Oct4, Sox2, Klf4, Myc, and pig Nanog were performed following the protocols 
described by (Choi et al. 2016). 
 
3. Culture and growth of pESCs  
 
pESCs were derived from blastocysts produced in vitro. The produced and hatched 
blastocysts were seeded onto feeder cells composed of mitotically inactivated MEFs 
according to previous studies (Son et al. 2009; Park et al. 2013). After 5–7 days, primary 
colonies of ESCs were observed and cultured for approximately 7–10 days. Fully 
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expanded colonies, mechanically dissociated via trituration with pulled-glass pipettes, 
were transferred onto new feeder cells for subculturing. 
pESCs were cultured in pESC medium (PESM) consisting Dulbecco’s modified 
Eagle’s medium (DMEM; low glucose), Ham’s F10 medium containing 15% fetal 
bovine serum (FBS; collected and processed in the USA), 2 mM GlutaMAX, 0.1 mM 
ß-mercaptoethanol, and 1× antibiotic/antimycotic (Gibco, USA). To support 
pluripotency and self-renewal, the ESCs were cultured in PESM with 20 ng/mL human 
recombinant bFGF (hrbFGF; R&D Systems), and 100 ng/mL heparin sodium salt 
(Sigma-Aldrich, USA). For the analysis of overexpressed genes, the transfected cells 
were cultured in medium supplemented with 2 ng/mL DOX and 1,000 unit/mL LIF 
(Millipore, MA, USA). The medium was changed every 24 h and all cells were cultured 
in humidified conditions with 5% CO2 at 37°C. pESCs were subcultured every 5–7 days 
using pulled-glass pipettes. Expanded colonies were detached from the feeder cells and 
dissociated into small clumps. They were transferred onto new feeder cells containing 
mitomycin-C-treated (Roche, Germany) MEFs. 
 
4. AP staining  
  
AP staining was performed using the nitro blue tetrazolium chloride/5-bromo-4-
chloro-3-indolyl phosphate toluidine salt (NBT/BCIP; Roche) method. Before staining, 
all cells were preincubated for 10 min at 4°C and fixed with 4% paraformaldehyde for 
20 min. After washing, fixed cells were incubated for 30 min at room temperature in 
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the dark with NBT/BCIP stock solution diluted in buffer solution (0.1 M Tris-HCl, 0.1 
M NaCl, pH 9.5). The cells were examined under an inverted microscope. 
 
5. Embryoid body formation and in vitro differentiation of pESCs  
 
To evaluate the capacity for in vitro differentiation, embryoid bodies (EBs) were 
generated from pESCs. Cultured ESC colonies were detached from the feeder cells, and 
colonies were mechanically dissociated into small clumps. These clumps were cultured 
in Petri dishes without cytokines for 5 days. After suspending the culture, the 
dissociated cells aggregated and formed EBs. The cultured EBs were seeded onto 0.1% 
gelatin-coated plates and further cultured for 2 weeks with DMEM containing 15% FBS. 
After 2 weeks, differentiated cells were analyzed using reverse transcription (RT)-PCR, 
qPCR, and immunostaining with differentiation-specific antibodies. 
 
6. Immunocytochemistry staining  
 
Immunocytochemistry analyses were performed to evaluate the expression of genes 
related to pluripotency and differentiation. Before staining, all cells were preincubated 
for 10 min at 4°C and fixed with 4% paraformaldehyde for 30 min. After washing twice 
with Dulbecco’s phosphate-buffered saline (DPBS; Welgene), samples were treated for 
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1 h with 10% goat serum in DPBS to prevent nonspecific binding. Then, the cells were 
incubated overnight at 4°C with the primary antibodies as follows: anti-Oct4 (Santa 
Cruz Biotechnology, CA, USA; 1:200), anti-Sox2 (Millipore; 1:200), anti-Nanog (Santa 
Cruz Biotechnology; 1:200), anti-Neurofilament (Millipore, 1:100), anti-Vimentin 
(Millipore; 1:100), and anti-Cytokeratin17 (Millipore; 1:100). When using antibodies 
for intracellular proteins such as Oct4, Sox2, and Nanog, fixed cells were treated for 5 
min with 0.2% Triton X-100 (Sigma-Aldrich. After incubating with the primary 
antibody, the cells were treated for 3 h at room temperature with Alexa Fluor-conjugated 
secondary antibodies. Nuclei were stained with Hoechst 33342 (Molecular Probes, 





7. RT-PCR  
 
Total RNA was extracted from the cells using TRIzol Reagent (Invitrogen, USA) 
according to the manufacturer’s instructions. Complementary DNA (cDNA) was 
synthesized using the High Capacity RNA-to-cDNA Kit. cDNA was amplified with 2× 
PCR master mix solution (iNtRON, Korea) and 2 pmol of primers, as shown in Tables 
2 and 3. PCR reactions were performed in a thermocycler under the following 
conditions: 94°C for 5 min, 35 cycles of denaturation at 95°C for 30 s, annealing for 30 
s (where the annealing temperatures depended on each primer set), extension at 72°C 
for 30 s, and a final extension at 72°C for 7 min. Amplified PCR products were 
visualized using electrophoresis on 1% agarose gel stained with ethidium bromide. 
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Table 2. Primer sets used to detect differentiation markers. 


















































Table 3. Primers sets used for the detection of transgene insertion in cDNA. 
 
  





























8. Quantitative real-time polymerase chain reaction (qPCR)  
 
To verify the gene expression levels in pESCs, I performed qPCR. Total RNA from 
individual samples was extracted using TRIzol Reagent (Invitrogen) according to the 
manufacturer’s instructions. cDNA was synthesized using the High-capacity RNA-to-
cDNA Kit (Applied Biosystems, CA, USA) according to the manufacturer’s 
instructions, and a final volume of 20 µL of cDNA was produced. Extracted cDNA 
samples were amplified with the DyNAmo HS SYBR Green qPCR Kit (Thermo 
Scientific, MA, USA) containing 1 pmol of each primer set listed in Table 4 in a 10-µL 
reaction volume. Amplification and detection were conducted using the ABI 7300 Real-
Time PCR System (Applied Biosystems) under the following conditions: one cycle of 
denaturation at 50°C for 2 min and 95°C for 10 min, 40 cycles of denaturation at 95°C 
for 15 s, and annealing/extension for 1 min (where the annealing/extension 
temperatures depended on each primer set). The relative expression level was calculated 
by normalizing the threshold cycle (Ct) values of each gene to that of ACTB using the 




Table 4. Primers sets used for qPCR. 











































9. Statical anlaysis  
 
The gene expression data from the qPCR analysis data were statistically analyzed 
using GraphPad Prism 6 statistical software (GraphPad Software, CA, USA). All 
Statistical differences in the datasets (except those presented in Fig. 2E) were 
determined using one-way analyses of variance (ANOVAs) followed by Fisher’s least 
significant difference test. The statistical differences in the data presented in Figure 2E 
were investigated using ANOVA followed by the Bonferroni post-hoc test. Differences 




















Characterization of pESCs  
The pESC cell line used in this study was generated from porcine preimplantation 
blastocysts using in vitro fertilization in a manner reported previously (Lee et al. 2007). 
The established pESC cell line was flat, similar to previous reports of hESCs and mouse 
EpiSCs (Fig. 1A) (Park et al. 2013). In addition, they possessed AP activity (Fig. 1B), 
were stably maintained in their pluripotent state over > 40 passages in 1 year. The cells 
were analyzed for pluripotent marker expression and their capacity for in vitro 
differentiation according to standards reported previously (Park et al. 2013). Expression 
of transcription factors related to pluripotency such as Oct4, Sox2, and Nanog was 
examining using immunocytochemistry (Fig. 1C). The cells were detached from feeder 
cells and cultured in suspension to verify their capacity for differentiation. The pESCs 
cultured in suspension formed EBs (Fig. 1D, left panel). The generated EBs 
spontaneously differentiated into the three germ layers upon placement on gelatin-
coated plates (Fig. 1D, right panel). In the differentiated cells, the expression of 
differentiation marker genes in the three germ layers was detected by RT-PCR and 
immunostaining (ectoderm: PAX6, NESTIN, CRABP2, Neurofilament; mesoderm: 
ENO1, BMP4, DES, Vimentin; endoderm: SOX17, GATA4, AMY2, Cytokeratin17). 
Thus, we confirmed that the established cell line was pluripotent with the differentiation 
potential to generate the three germ layers (Fig. 1E-F). 
We performed an experiment to observe the changes that occurred when 
reprogramming factors were overexpressed in the pESCs. First, DOX-inducible vectors 
carrying Oct4, Sox2, Nanog, Klf4, or Myc, known as reprogramming factors, were 
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transduced into pESCs. The cells were stabilized, and then cultured in medium 
supplemented with LIF and DOX or bFGF and DOX. Some of the single-gene 
overexpression groups were used for gene expression analysis and others were 
maintained for morphological observations. Based on the results of the gene expression 
analysis, combinations of two reprogramming factors were introduced into the pESCs 
and the culture medium was replaced with LIF- and DOX-supplemented medium. The 
two-gene transduced pESCs were cultured in exchanged medium for 2, 4, or 6 days, 
and then sampled for analysis of endogenous gene expression patterns and pESC 












Figure 1. Characterization of pESCs.  
(A) Colony morphology of pESCs. (B) pESCs stained for alkaline phosphatase 
activity. (C) Oct4, Sox2, and Nanog expressed via immunostaining. (D) Embryoid 
bodies (EBs) formed by pESCs cultured in suspension. The EBs differentiated into 
three germ layers on gelatin-coated plates (left panel: EBs, right panel: differentiated 
EBs). (E) Reverse transcription PCR analysis for marker genes of the three germ layer 
expressed in the differentiated EBs (M: size marker; ectoderm markers: Pax6, Nestin, 
Crabp2; mesoderm markers: Eno1, Bmp4, Des; endoderm markers: Sox17, Gata4, 
Amy2). Immunostaining of Cytokeratin17 (endoderm), Vimentin (mesoderm), and 
Neurofilament (ectoderm) expressed in differentiated EBs. (G) Schematic overview of 







Observation of pESCs with single-factor overexpression  
 A single reprogramming factor was introduced into pESCs using the tetracycline-
inducible system (Fig. 2D). In the Tet-Off state, the pESCs with single-factor 
overexpression formed flat colonies and exhibited AP activity, similar to typical pESCs. 
However, when DOX was added to the medium to activate the transgene, the pESCs 
lost their typical characteristics. The cell mass of the pESCs decreased gradually, the 
boundary of the colony became obscured, and AP activity was lost (Fig. 2B). As the 
subculture progressed, the transgene-activated experimental groups became 
differentiated (Fig. 2C). To analyze these results based on endogenous gene expression, 
we performed qPCR (Fig. 3A–H). Prior to this experiment, we found that lentiviral 
infection had no effect on gene expression (Fig. 2E). The pESCs with single-factor 
overexpression were cultured for 3 days on LIF- and DOX-supplemented medium, 
because long-term culture was not possible. We selected gene candidates for qPCR 
based on a reprogramming process (early phase: E-cadherin; intermediate phase: Lin28 
and Sall4; late phase: Rex1, Fut4, Klf2 and Dax1) and a representative pluripotent 
marker (Oct4) (Buganim et al. 2012; Golipour et al. 2012; Hansson et al. 2012; Polo et 
al. 2012). Analysis of the qPCR results revealed that most ectopic factors did not 
downregulate endogenous genes in the pESCs. However, the experimental group with 
Oct4 and Sox2 exhibited significant upregulation of several endogenous genes in 
pESCs. The Oct4 overexpression group induced upregulation in endo-Oct4, Fut4, and 





Figure 2. Reprogramming factor-transduced pESCs morphology and 
alkaline phosphatase activity. 
(A) Without doxycycline (DOX), reprogramming factor-transduced pESCs showed 
colony morphologies and alkaline phosphatase activity. (B) When cultured with 
medium containing leukemia inhibitory factor (LIF) + DOX or bFGF + DOX, colony 
morphologies and alkaline phosphatase activity of reprogramming factor-transduced 
pESCs. (C) After subculturing treated with LIF + DOX or bFGF + DOX, colony 
morphologies and alkaline phosphatase activity of reprogramming factor-transduced 
pESCs. (D) The integration of reprogramming factors into the genome was confirmed. 
(hOCT4-pESCs: hOct4 transduced pESCs; hSOX2-pESCs: hSox2 transduced pESCs; 
pNANOG-pESCs: pNanog transduced pESCs; hKLF4-pESCs: hKlf4 transduced pESCs; 
hMYC-pESCs: hMyc transduced pESCs)  (E) To test whether lentiviral infection 
affects gene expression, we performed quantitative PCR analysis of M2rtTA infected 








Figure 3. Analysis of pluripotent-related gene expression using quantitative 
reverse transcription (qRT)-PCR.   
Three days after treatment with LIF and DOX, the expression of endogenous 
pluripotent-related genes, including (A) Oct4, (B) Rex1, (C) Fut4, (D) Klf2, (E) Dax1, 











Characteristics of pESCs with two overexpressed factors  
Based on the analysis of overexpressed pESCs, we transduced two factors into the 
pESCs. DOX-inducible lentiviral vectors with a combination of Oct4 and Sox2, Oct4 
and Nanog, Oct4 and Klf4, or Sox2 and Nanog were introduced into pESCs. Typical 
colony morphology and AP activity of pESCs were observed in the Tet-Off state (Fig. 
4A). However, when the transgene was activated using LIF- and DOX-supplemented 
media, the pESCs with two overexpressed factors showed a different appearance from 
the control group, including decreased cell mass and AP activity (Fig. 4B). 
Interestingly, when one reprogramming factor was introduced, AP activity was lost 
completely, but when two reprogramming factors were introduced, weak AP activity 
remained. In addition, several of the groups transduced with two reprogramming 
factors could be maintained after subculturing, with transgene activation. Although 
long-term culture failed, pESCs with Oct4 and Nanog, Oct4 and Klf4, or Sox2 and 
Nanog could be subcultured even under transgene activation conditions. We were able 
to observe the colonies for about two weeks. However, the remaining groups were 
differentiated after subcultivation in transgene-activated states (Fig. 4C). Based on 
these results, we observed changes in endogenous genes related to pluripotency when 
two reprogramming factors were overexpressed in pESCs. Transgenes were activated 
and qPCR was performed in samples collected after culturing for 2, 4, and 6 days. In 
total, four groups, including the three experimental groups that could be subcultivated 
in the transgene activation state and a group with Oct4 and Sox2, were observed. The 
analysis of the qPCR results showed that E-cadherin, an early-phase reprogramming 
marker, was upregulated on day 2, and then decreased slightly on day 4 and maintained 
54 
 
a similar level on day 6. Conversely, the intermediate-phase reprogramming markers 
Lin28 and Sall4 increased more than ten-fold on day 2, and 40-fold in the Sox2 and 
Nanog transduction group. However, on day 4, they tended to decrease sharply and 
showed little expression on day 6. The late-phase reprogramming markers Fut4, Rex1, 
and Klf2 were not expressed throughout the experiment. Meanwhile, Dax1 was 





Figure 4. Morphology and alkaline phosphatase activity of two-
reprogramming-factor-transduced pESCs. 
(A) Without doxycycline, two-reprogramming-factor-transduced pESCs showed 
typical colony morphologies. (B) When cultured with medium containing LIF and 
DOX, colony morphologies and alkaline phosphatase activity of two-reprogramming-
factor-transduced pESCs. (C) Colony morphologies of two-reprogramming-factor-







Figure 5. Quantitative reverse transcription PCR analysis of pluripotent-
related genes in two-factor-transduced pESCs. 
To verify the effects of ectopic gene expression on endogenous genes, expression of 
endogenous genes representing pluripotency and the reprogramming phase 
[pluripotency markers: Oct4 (A); early phase marker: E-cadherin (B); intermediate 
phase markers: Lin28 (C) and Sall4 (D); late phase markers: Fut4 (E), Rex1 (F), Klf2 
(G), and Dax1 (H)] were determined by quantitative PCR. Each group was harvested 
at days 2, 4, and 6 after treatment with DOX- and LIF-supplemented medium. All data 
















The experimental groups overexpressing one reprogramming factor in pESCs may 
have differentiated because of an imbalance in their pluripotency network. 
Pluripotency networks are balanced by a number of genes with complex mechanisms 
(e.g., antagonism, synergistic action, and additive interaction). (Niwa, Miyazaki, and 
Smith 2000) reported that Oct-3/4 expression should be maintained at an appropriate 
level for mESCs to remain undifferentiated. In this study, a two-fold increase in the 
expression of Oct-3/4 in mESCs led to differentiation into primitive endoderm and 
mesoderm. Conversely, after (Niwa, Miyazaki, and Smith 2000) lowered the 
expression Oct-3/4 level, the cells differentiated into TE. In another study, Nanog was 
overexpressed in EpiSCs and hESCs. The results of this study suggested that hESCs 
with overexpressed Nanog failed to differentiate into ectoderm and definitive 
endoderm. Based on the results of this experiment and previous studies (Niwa, 
Miyazaki, and Smith 2000), if the precise expression levels of reprogramming factors 
in pESCs are not maintained, the pluripotent balance can be broken. Meanwhile, 
EpiSCs transduced with Klf4 resulted in the successful formation of germline-
competent chimeras and naïve marker expression (Guo et al. 2009). In addition, Klf2 
was introduced into EpiSCs instead of Klf4 and cultured with 2i and LIF to support the 
conversion into a naïve-like state (Hall, Guo, et al. 2009). Together, these studies show 
that even in the same primed pluripotent state, cells differ in their pluripotent networks 
depending on species and strains. 
Although pESCs with one overexpressed reprogramming factor were not maintained 
in this experiment, the results showed that Oct4 and Sox2 acted as triggers for the 
transient high expression of endogenous Oct4, Fut4, and E-cadherin in pESCs. In many 
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studies, Oct4 has an important role in the maintenance of pluripotency and 
reprogramming of differentiated cells (Vallier et al. 2009; Zafarana et al. 2009; Li et 
al. 2010). The results from Oct4-centered protein interaction analysis and genome-
wide identification of the Oct4 target gene indicate that Oct4 co-binds with 
pluripotency regulators. These results demonstrate that Oct4 has an important role in 
maintaining the undifferentiated state of ESC (Pardo et al. 2010; van den Berg et al. 
2010). Sox2 is another essential element in maintaining the pluripotency of ESCs, as 
verified by Sox2 null ESCs that differentiated into TE-like cells because Sox2 is related 
in the maintenance of orphan nuclear receptors such as Nr5α2. Nr5α2 is associated 
with the activity of Oct4 combined with the Oct4 proximal promoter (Masui et al. 2007). 
In addition, endogenous Sox2 expression is an event necessary to reprogram somatic 
cells into iPSCs. Endogenous Sox2 expression induces the reprogramming of the next 
event to occur and the expression of genes related to pluripotency such as Lin28, Esrrb, 
and Sall4 (Buganim et al. 2012). These results and previous reports suggest that Oct4 
and Sox2 are key transcription factors in pluripotency networks and that they interact 
with a variety of genes related to pluripotency. 
Based on the experimental results, all of the two-factor transduction pESC treatment 
groups failed long-term culturing. The qPCR analysis offered several reasons for this 
failure. Self-renewal by LIF signaling is a characteristic of cells with naïve 
pluripotency. Therefore, to cultivate primed pESCs with primed pluripotency in LIF-
supplemented media, reprogramming is required. However, in the pESCs transduced 
with two reprogramming factors, the expression of genes expressed at the intermediate 
phase of reprogramming was not maintained. E-cadherin, which was expressed early 
62 
 
in reprogramming, showed an mRNA expression level increased by six-fold or more 
on day 2, which decreased slightly on day 4 and was maintained until day 6. However, 
Lin28 and Sall4, which are expressed in the intermediate phase of reprogramming, 
were expressed only on day 2, and then decreased rapidly and were not expressed on 
day 6. Therefore, the naïve marker genes Rex1, Fut4, and Klf2 were not expressed after 
day 2. These results demonstrate that reprogramming factor transduction in pESCs 
failed to induce reprogramming. 
Like pESCs, the pluripotency states of hESCs and EpiSCs with primed pluripotency 
have been successfully converted by introducing two reprogramming factors (Silva et 
al. 2009; Hanna et al. 2010; Yang et al. 2010). However, the reprogramming conditions 
of mouse and humans cells do not apply to pigs, because the molecular mechanisms 
during embryo development differ. Pigs require a longer period of time before embryos 
are implanted than mouse and human (Alberio and Perez 2012). Therefore, the 
signaling that regulates the pluripotency of pig ICM differs from that of mouse embryo. 
Unlike mouse, pigs express Oct4 and Cdx2 in ICM and TE. Conversely, Sox2 is 
expressed from the beginning of embryo cavitation, and when it is divided into TE/ICM, 
it appears specifically only in the embryonic portion and gradually disappears with the 
progression of differentiation. ICM cells and epiblasts of pig blastocysts do not have 
LIF receptors, whereas FGF receptors are highly expressed. Therefore, FGF signaling 
has a critical role in maintaining pluripotency in pigs than LIF signaling (Hall, 
Christensen, et al. 2009). In addition, strong expression of BMPr and SMAD in porcine 
ICM cells and EpiSCs was detected by immunostaining and BMP signaling inhibitor 
experiments in vitro. When pig ICM cells and EpiSCs cells were treated with BMP 
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inhibitors in vitro, the survival rate of the cells decreased (Hall and Hyttel 2014). BMP 
signaling also has an important role in maintaining pig pluripotency. Recently, (Zhang 
et al. 2015) succeeded in generating ‘intermediate’ pig pluripotent stem cells with both 
naïve and primed characteristics even when the transgene was removed using three 
growth factors (LIF, FGF2, and BMP4) and the inhibitor 2i. These results show that 
pig pluripotent stem cells maintain pluripotency by unique cell signaling that differs 
from those of mouse and human. 
 There are cases of the successful establishment of pig naïve-like pluripotent stem 
cells by introducing two reprogramming factors. Roberts et al. (2011) transduced Oct4 
and Klf4 into the ICM of porcine blastocysts and isolated pESCs. These pESCs were 
self-renewed by LIF, and their ability to differentiate into the three germ layers was 
verified using the teratoma formation assay (Telugu et al. 2011). This suggests that 
transducing reprogramming factors to establish porcine naïve-like pluripotency cells 
via reprogramming factor transduction methods can be effectively used to gain a 
pluripotent cell source with low epigenetic memory. Overall, these results indicate that 
pig-specific culture systems or reprogramming methods are required to obtain pig 
naïve pluripotent stem cells. 
These results indicate that pig-specific strategies are required to obtain pig naïve 
pluripotent stem cells. Present experiment was the first attempt to convert pluripotency 
state into naïve state by transducing ectopic factor into established pESCs. In this 
experiment, we were also able to easily understand how the introduction of exogenous 
factors, commonly used reprogram in other primed pluripotent stem cells, affects the 
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regulation of endogenous pluripotent related genes in pESCs. In the experiment, human 
factor was used to distinguish between endogenous gens and ectopic factors. I wonder 
that results would have been obtained if pig originated factors were introduced into 
pESCs. Later, I would like to study the gene network analysis of pESCs by introducing 
pig derived factors. Especially in a recent report, Sox2 has been reported as a true 
porcine pluripotency marker (Liu et al. 2015), and it is expected that some changes will 
occur when pig originated Sox2 is introduced into pESCs. In addition to the expressed 
gens, there were notable differences in naïve and primed pluripotent cells (Table 1). It 
was also possible to attempt to perform a pluripotency state conversion using these 
characteristics. In particular, the naïve and primed pluripotent states differ in the 
intracellular signaling, which maintains pluripotency. Using these characteristics, we 
could try switching the pluripotency state by screening the signaling mechanisms that 
make up pESCs and mESCs, artificially using chemical to induce pESCs signaling 
similar to mESCs. By accessing the pESCs pluripotent network in these various ways, 
we could better understand the functions and systems of each factor of the network. 











In this study, all experimental groups in which one or two reprogramming factors 
were transduced into pESCs failed to show long-term cultivation in LIF-supplemented 
medium. Based on qPCR analysis performed to determine the reasons for this failure, 
the expression of both Lin28 and Sall4 genes was not maintained. Since these two 
genes are markers expressed at the intermediate stage of reprogramming, it can be 
presumed that the expression of both genes was not maintained because the 
intermediate stage of reprogramming was not completed. Based on these results, 
additional strategies are required to complete each reprogramming phase to succeed in 
converting pESCs into a pluripotent state. Overall, to support the conversion of pESCs 
into a pluripotent state, a greater understanding of the process is required to identify 
the unique pluripotency network in pig and to determine whether bona fide pig 
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SUMMARY IN KOREAN 
 쥐, 인간 그리고 돼지의 유전학적 배경이 다르므로 돼지 배아줄기세포를 
확립하는 것은 여전히 어려운 일이다. 그러므로 돼지 배아줄기세포를 
확립하기 위해서는 돼지 특이적인 만능성 마커와 세포 신호기작에 대한 
연구가 필요하다. 본 연구에서는 돼지의 만능성 유전자 네트워크를 
분석하기 위해 리프로그래밍 팩터로 알려진 Oct4, Sox2, Nanog, Klf4 
그리고 Myc 유전자를 독시사이클린 유도성 벡터를 이용해서 각각 돼지 
배아줄기세포에 도입시켰다. 하나의 유전자를 도입시킨 처리군을 bFGF만 
첨가된 배지로 배양하면, 돼지 배아 줄기세포는 안정적으로 유지된다. 
그러나 독시사이클린이 첨가된 배지로 실험군을 배양하면, 돼지 배아 
줄기세포는 알칼리포스파타제에 대한 활성을 잃고, 분화되었다. 이어서, 
우리는 독시사이클린을 처리한 돼지 배아 줄게 세포의 유전자 발현을 
qRT-PCR을 사용해서 분석했다. 그 결과, Oct4와 Sox2 과발현 그룹에서 
만능성 관련 내재 유전자들의 발현이 유의적으로 높아진 것을 발견했다. 
Oct4 유전자를 과발현시킨 처리군에서 세포 내재 Oct4, E-cadherin 
그리고 Fut4 유전자의 발현이 유의적으로 증가했고, Sox2유전자를 
과발현시킨 처리군에서는 세포 내재 Fut4 유전자의 발현이 유의적으로 
증가했다. 이러한 결과를 바탕으로 Oct4나 Sox2 중 한 가지를 포함하는 
두 가지 리프로그래밍 팩터의 조합을 독시사이클린 유도성 벡터에 실어 
돼지 배아줄기세포에 도입시켰다. 그 후 독시사이클린이 첨가된 배지로 
배양했더니, 알칼리포스파타제에 대한 활성이 희미하게 남아있었고, 몇몇 
실험군은 계대 후에도 배양을 유지 할 수 있었다. 비록 장기 배양에는 
실패했지만, Oct4와 Nanog, Oct4와 Klf4 그리고 Sox2와 Nanog의 조합을 
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돼지 배아줄기세포에 도입했을 때, 전이유전자들이 활성인 상태에서도 
계대가 가능했다. 장기 배양에 실패한 원인을 qRT-PCR로 분석해보니, 
리프로그래밍 중기에 발현하는 마커들의 발현이 유지되지 않았음을 알 수 
있었다. 이러한 결과를 바탕으로, 돼지 배아줄기세포의 만능성 상태 전환을 
위해서는 리프로그래밍 각 단계를 완료시킬 수 있는 추가적인 방법이 
필요하다는 것을 알 수 있다. 이 연구를 통해 돼지 만능성 네트워크의 
이해를 증진하고, 진정한 의미의 돼지 만능성 세포를 확립하는 것에 
도움이 되었으면 한다. 
주요어 : 배아줄기세포, 리프로그래밍 팩터, 만능성, 돼지 
학번 : 2014-22931 
